A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients

NCT00077610 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

673

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Epoetin alfa or beta
DRUG: RO0503821 (1x/2 Weeks)
DRUG: RO0503821 (1x/4 Weeks)

Sponsor

Hoffmann-La Roche